Frequency, predictors, and consequences of maintenance infliximab therapy intensification in ulcerative colitis
Introduction: Infliximab (IFX) therapy intensification in ulcerative colitis (UC) is more common than established in pivotal studies. Objectives: To establish the frequency and form of intensification for UC in clinical practice, as well as predictors, and to compare outcomes between intensified and...
Main Authors: | Luis Fernández-Salazar, Jesús Barrio, Fernando Muñoz, Concepción Muñoz, Ramón Pajares, Montserrat Rivero, Vanesa Prieto, Jesús Legido, Abdel Bouhmidi, Maite Herranz, Guillermo González-Redondo, Nereida Fernández, Fernando Santos, Ramón Sánchez-Ocaña, Diana Joao |
---|---|
Format: | Article |
Language: | English |
Published: |
Aran Ediciones
2015-09-01
|
Series: | Revista Espanola de Enfermedades Digestivas |
Subjects: | |
Online Access: | http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1130-01082015000900002&lng=en&tlng=en |
Similar Items
-
Infliximab induces clinical, endoscopic and histological responses in refractory ulcerative colitis Infliximab induce respuesta clínica, endoscópica e histológica en la colitis ulcerosa refractaria
by: F. Bermejo, et al.
Published: (2004-02-01) -
Pyoderma gangrenosum associated with ulcerative colitis: response to infliximab Pioderma gangrenoso asociado a colitis ulcerosa: respuesta a infliximab
by: A. López San Román, et al.
Published: (2004-06-01) -
Is safety infliximab during pregnancy in patients with inflammatory bowel disease?
by: Federico Argüelles-Arias, et al. -
Is safety infliximab during pregnancy in patients with inflammatory bowel disease? ¿El tratamiento con infliximab es seguro durante el embarazo en pacientes con enfermedad inflamatoria intestinal?
by: Federico Argüelles-Arias, et al.
Published: (2012-02-01) -
Hepatitis B reactivation and current clinical impact Reactivación de la hepatitis B y su impacto clínico actual
by: B. Álvarez Suárez, et al.
Published: (2010-09-01)